Molecular Targets in Lung Cancer: Study of the Evolution of Biomarkers Associated with Treatment with Tyrosine Kinase Inhibitors—Has NF1 Tumor Suppressor a Key Role in Acquired Resistance?

  1. Alen, B.O.
  2. Estévez-Pérez, L.S.
  3. Hermida-Romero, M.T.
  4. Reguera-Arias, A.
  5. García-Campelo, R.
  6. de la Torre-Bravos, M.
  7. Concha, Á.
Revista:
Cancers

ISSN: 2072-6694

Ano de publicación: 2022

Volume: 14

Número: 14

Tipo: Artigo

DOI: 10.3390/CANCERS14143323 GOOGLE SCHOLAR lock_openAcceso aberto editor

Obxectivos de Desenvolvemento Sustentable